Follow
Dogancan Ozturan
Dogancan Ozturan
Verified email at ubc.ca - Homepage
Title
Cited by
Cited by
Year
Functional mapping of androgen receptor enhancer activity
CCF Huang, S Lingadahalli, T Morova, D Ozturan, E Hu, IPL Yu, S Linder, ...
Genome biology 22 (1), 149, 2021
192021
Androgen Receptor-Mediated Transcription in Prostate Cancer
D Özturan, T Morova, NA Lack
Cells 11 (5), 898, 2022
162022
Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo
A Kayabolen, U Akcan, D Özturan, H Ulbegi‐Polat, GN Sahin, ...
Advanced Science 9 (27), 2201294, 2022
102022
The “Ins and Outs” of Prostate Specific Membrane Antigen (PSMA) as Specific Target in Prostate Cancer Therapy
F Eltit, N Robinson, PLI Yu, M Pandey, J Lozada, Y Guo, M Sharma, ...
Advances in Molecular Pathology, 291-308, 2023
2023
Decoding the Epigenetics and Chromatin Loop Dynamics of Androgen Receptor-Mediated Transcription
UB Altintas, JH Seo, C Giambartolomei, D Ozturan, B Fortunato, G Nelson, ...
bioRxiv, 2023.12. 22.573134, 2023
2023
Androgen Receptor-dependent Enhancers in Prostate Cancer
D Özturan
Koç University, 2021
2021
Protein scaffold-based multimerization of soluble ACE2 efficiently blocks SARS-CoV-2 infection in vitro and in vivo
A Kayabolen, U Akcan, D Ozturan, H Ulbegi-Polat, GN Sahin, ...
BioRxiv, 2021
2021
Genome-wide AR enhancer activity in prostate cancer
D Ozturan, F Huang, T Morova, M Saffarzadeh, NA Lack
Cancer Research 79 (13_Supplement), 5208-5208, 2019
2019
Structural characterization of androgen receptor variant 7 in prostate cancer
F Özgün, Z Kaya, H Bayraktar, S Manioğlu, D Özturan, N Lack
Cancer Research 77 (13_Supplement), 3522-3522, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–9